BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• BioMidwest

  Genovis Publish a New Share Issue Prospectus

  April 4, 2011

   · 

  1 min read
• Drug Development

  Boehringer Ingelheim Corporation’'s Lead Hepatitis C Compound Moves into Phase 3 - the First Within the BI HCV Portfolio

  April 4, 2011

   · 

  4 min read
• Labopharm Inc. Receives Notice From Nasdaq Regarding Minimum Market Value Of Listed Securities

  April 4, 2011

   · 

  3 min read
• Biotech Bay

  Eli Lilly and Company’s Axiron(R) (Testosterone) Topical Solution CIII Now Available in Pharmacies

  April 4, 2011

   · 

  7 min read
• Business

  RSB Spine Announces Record First-Quarter 2011 Revenue

  April 4, 2011

   · 

  1 min read
• Drug Development

  Idera Pharmaceuticals, Inc. Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011

  April 4, 2011

   · 

  10 min read
• Business

  Applied Nanotech Holdings Appoints YHCC Executive, Xin Li, to Its Board of Directors

  April 4, 2011

   · 

  1 min read
• Drug Development

  TxCell Receives Approval for a Phase I/II Clinical Trial in Rheumatoid Arthritis

  April 4, 2011

   · 

  3 min read
• GE Healthcare Launches Prepacked Gravity-Flow Columns for Manual Antibody Purification

  April 4, 2011

   · 

  1 min read
• Drug Development

  Cyclacel Pharmaceuticals, Inc. Announces Presentation of Preclinical Data Demonstrating Combination Potential of Clinical Agents at American Association for Cancer Research Annual Meeting

  April 4, 2011

   · 

  1 min read